Delivery Order SPE2DB22D1202-SPE2DB25FUYJ9

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D1017|SPE2DB25FG0PS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,599.62 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $2,390.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Nurtec ODT 75 MG Tablet 8S, a medication used to treat migraines. The contract has a firm fixed price and an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN90J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $71,933.75 firm fixed-price delivery order is for the supply of Nurtec ODT 75 MG tablets. The contract has an ultimate completion date of April 17, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $17,769.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is not set-aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, identified as SPE2DB24D1007 and SPE2DB25FCBFE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $19,538.19 and an ultimate completion date of April 11, 2025. The contract is not set aside and represents open competition. AmerisourceBergen Drug Corp is the prime contractor and...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FDV52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,327.73 firm fixed-price delivery order is for Nurtec ODT 75 mg tablets, with an ultimate completion date of October 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $18,027.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Nurtec ODT 75 mg tablets, a prescription medication used to treat migraines. The contract has a firm fixed-price pricing type and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $5,071.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Nurtec ODT 75 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $21,024.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FUXEQ) under Amerisourcebergen's existing Indefinite Delivery Contract (SPE2DB25D3018) with DLA, which has a ceiling value of $999,999,999.00 and provides comprehensive global pharmaceutical support through December 2026. The current delivery order is for the supply of Nurtec ODT 75 mg...
This federal contract award, valued at $18,070.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. This award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 that...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUYJ9
    Delivery Order

This federal contract award, SPE2DB22D1202|SPE2DB25FUYJ9, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $25,478.68 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of April 21, 2025 and is not a set-aside award, indicating open competition.

AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC), SPE2DX, with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/18/25, 10:04 AM